Fexofenadine suspension formulation
US8933097B2 · kind B2 · utility
1Cited by
2References
88Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2008 |
| Grant date | Jan 13, 2015 |
| Priority date | — |
| Expiry date | Aug 16, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.